Rainbow Children's Medicare Limited (RCML) is a specialized healthcare provider focused on pediatric and women's care services. Founded in 1999 by Dr. Ramesh Kancharla, a pediatric gastroenterologist, the company was established to address the scarcity of high-quality, dedicated pediatric healthcare in India. The company operates under two primary brands: "Rainbow Children's Hospital" for pediatric services and "Birthright by Rainbow" for women's care. It has grown to become the largest pediatric hospital chain in the country, with a significant presence across 6 states and 9 cities. The network comprises 23 hospitals and 5 outpatient clinics, with a total capacity of 2,375 beds.

RCML's service offerings are comprehensive, spanning the full spectrum of care from secondary to quaternary levels. Pediatric services include general pediatrics, immunizations, neonatal and pediatric intensive care (NICU/PICU), and a wide range of multi-specialty services such as pediatric cardiology, neurology, oncology, and organ transplantation. The company allocates approximately one-third of its beds to critical care, underscoring its focus on complex cases. The "Birthright" brand provides integrated perinatal services, including complex obstetrics, fetal medicine, fertility treatments, and gynecology, creating a synergistic model where pediatric and maternal care are seamlessly coordinated under one roof.

The company's operational strategy is built on a "Hub and Spoke" model. Large, centrally located "hub" hospitals (150-250 beds) offer advanced tertiary and quaternary care, while smaller "spoke" facilities (50-100 beds) provide primary, secondary, and basic tertiary care in surrounding areas, referring complex cases to the hubs. This model is well-established in Hyderabad and is being replicated in other major cities to ensure wider coverage and operational efficiency. A key differentiator for RCML is its unique doctor engagement model, which relies on a large team of over 1,000 full-time, consultant-led doctors, ensuring 24/7 availability for critical services. This approach, combined with a strong in-house training program recognized by the National Board of Examinations, fosters high retention and a commitment to quality. The company has received numerous accolades, including JCI accreditation for its flagship hospitals, positioning it as a leader in specialized child and maternal healthcare.

Official Website: http://www.rainbowhospitals.in/

• Q3 FY26 Performance (YoY)

• Revenue from Operations: Increased by 11.9% to INR 4,454.5 million from INR 3,980.8 million in Q3 FY25.

• EBITDA (Post Ind AS 116): Grew by 9.4% to INR 1,469.8 million compared to INR 1,343.6 million in the prior year quarter.

• Profit After Tax (PAT): Rose by 7.2% to INR 739.0 million from INR 689.4 million.

• Key Expenses: Employee benefits expense saw a significant increase of 21.8% YoY, and professional fees to doctors grew by 14.5% YoY.

• 9M FY26 Performance (YoY)

• Revenue from Operations: Grew by 8.5% to INR 12,431.8 million from INR 11,457.6 million in 9M FY25.

• EBITDA (Post Ind AS 116): Increased by 6.5% to INR 3,994.6 million.

• Profit After Tax (PAT): Grew by 8.3% to INR 2,033.3 million.

• Payor Profile (Inpatient)

• For 9M FY26, the payor mix was 48.0% from cash and 52.0% from insurance. This shows a slight shift towards insurance payments compared to 9M FY25, which was 48.2% cash and 51.9% insurance.

The company has demonstrated consistent top-line and bottom-line growth, although expense growth, particularly in employee and doctor costs, has outpaced revenue growth in the recent quarter.

• Focused Child-Centric Model

• The company operates hospitals specifically designed for children, with soothing interiors and a child-friendly environment to aid faster recovery. A significant portion of capital expenditure is allocated to creating this congenial atmosphere.

• Integrated Perinatal Services

• RCML provides a full suite of services for both mothers and children under one roof. This integrated approach offers seamless coordination between obstetricians and pediatricians, which is crucial for perinatal and neonatal care.

• Hub and Spoke Operational Model

• This model allows for efficient scaling and market penetration. Large "hub" hospitals handle complex quaternary care, while smaller "spoke" hospitals provide primary and secondary care, creating a strong referral network within a city and its surrounding regions. This structure optimizes asset utilization and enhances accessibility for patients.

• Full-Time Doctor Engagement Model

• Unlike the common practice of engaging visiting consultants, RCML employs over 1,000 doctors on a full-time, retainer basis. This ensures 24/7 consultant-led service, which is critical for emergency and intensive care, leading to better clinical outcomes and fostering doctor loyalty.

• In-house Training and Development

• The company runs the largest pediatric DNB (Diplomate of National Board) training program in India's private sector. This creates a sustainable pipeline of medical talent trained in the company's protocols and culture, supporting its expansion needs.

RCML's specialized focus, integrated care model, and unique operational strategies create a strong competitive moat and a sustainable platform for growth.

• Operational Metrics Growth (Q3 FY26 vs Q3 FY25)

• Out-Patient (OP) Consultations: Increased by 18% to 417,342.

• In-Patient (IP) Discharges: Grew by 9% to 27,977.

• Deliveries: Increased by 16% to 5,354.

• Average Revenue Per Occupied Bed (ARPOB): Grew by 9% to INR 58,362.

• Network Expansion

• The company has been expanding through both greenfield projects and acquisitions. In 2025, it acquired Prashanthi Hospital in Warangal and Pratiksha Hospital in Guwahati. It also commenced operations at a new 100-bed hospital in Rajahmundry.

• The number of operational beds has increased by 18% YoY, from 1,935 in Q3 FY25 to 2,285 in Q3 FY26.

• New vs. Mature Hospitals

• New hospitals (under 5 years of operation) are showing strong momentum. The number of operational beds in new hospitals increased by 62% YoY in Q3 FY26.

• ARPOB for new hospitals grew by 14% YoY in Q3 FY26, indicating successful ramp-up and increasing acceptance in new markets.

The company is driving growth through a multi-pronged strategy of increasing patient volumes in existing facilities, expanding its physical network into new territories, and improving monetization at newer hospitals.

• Current Capacity

• As of December 31, 2025, the total network capacity stands at 2,375 beds, with 2,285 beds operational in Q3 FY26.

• Occupancy Rates (Q3 FY26)

• Overall Occupancy: 47.2%, a decline from 53.2% in Q3 FY25. This dilution is primarily due to the addition of new beds from recent expansions and acquisitions which are still in the ramp-up phase.

• Mature Hospitals Occupancy: 52.6%.

• New Hospitals Occupancy: 38.8%. The lower rate is expected as new facilities take time to achieve mature occupancy levels.

• Future Capex Indication

• The expansion plan outlines the addition of approximately 790 beds between the end of FY26 and FY29. This indicates a clear pipeline for future capital expenditure focused on building new hospitals in cities like Gurugram, Pune, Coimbatore, and Hennur.

While overall occupancy has temporarily dipped due to aggressive expansion, the planned capital expenditure on new facilities signals a continued focus on long-term growth.

• Bed Expansion Pipeline

• FY 25-26: Addition of ~60 beds in Hennur, Bengaluru.

• FY 26-27: Addition of ~130 beds in Coimbatore.

• FY 27-28: Addition of ~450 beds in Gurugram (two locations).

• FY 28-29: Addition of ~150 beds in Pune.

• This structured plan aims to increase total bed capacity to 3,165.

• Geographic Expansion

• The company is focused on strengthening its presence in the National Capital Region (NCR) with significant bed additions in Gurugram.

• Entry into new markets such as Pune and Coimbatore is planned to extend its footprint.

• Regional Strategy

• The company intends to replicate its successful "Hub and Spoke" model in Chennai and NCR.

• There is a stated intent to expand into tier-2 cities in Southern India, leveraging a regional "South Connect" model where city hubs support regional spokes.

The company has a clear and phased expansion roadmap aimed at deepening its presence in existing clusters and entering new high-potential geographies over the next four years.

• Quarterly Margins (Q3 FY26)

• EBITDA Margin: Stood at 33.0%, compared to 33.8% in Q3 FY25.

• PAT Margin: Was 16.6%, compared to 17.3% in Q3 FY25.

• Year-to-Date Margins (9M FY26)

• EBITDA Margin: 32.1%, slightly lower than 32.7% in 9M FY25.

• PAT Margin: Remained stable at 16.4%.

• Cost Structure Insights

• The slight margin compression in Q3 FY26 can be attributed to higher growth in operating costs relative to revenue. Employee benefits expense grew 21.8% YoY and professional fees to doctors grew 14.5% YoY, while revenue grew 11.9%. These costs are likely associated with staffing for newly opened and acquired hospitals.

Margins remain robust but have experienced slight compression due to investments in talent and resources for new hospital expansions, which are yet to reach full operational efficiency.

• Margin Pressure from Expansion

• New hospitals operate at lower occupancy and efficiency, leading to a temporary drag on overall margins. As seen in Q3 FY26, costs associated with expansion (employee expenses up 21.8% YoY) grew faster than revenue (up 11.9% YoY), which could continue to pressure profitability in the short term.

• Execution Risk

• The company has an ambitious expansion plan to add nearly 800 beds by FY29 in new and existing markets. Successful execution, including timely project completion and effective ramp-up of new facilities, is critical to achieving growth targets.

• Operational Efficiency Metrics

• The overall occupancy rate declined from 53.2% in Q3 FY25 to 47.2% in Q3 FY26. While driven by new bed additions, a sustained inability to ramp up utilization at new facilities could impact financial returns.

• Average Length of Stay (ALOS) has decreased from 2.91 days to 2.73 days YoY, which could impact revenue per patient if not offset by higher ARPOB.

The primary risks are operational, centering on the successful integration and ramp-up of new hospitals and managing the associated impact on margins and utilization rates.

• Leadership Appointment

• The company has appointed Mr. Abrarali Dalal as the Group Chief Executive Officer. He brings over 25 years of experience in leading large hospital networks, with a track record in operational excellence, brownfield expansions, and turnaround management.

• New Hospital Inauguration

• A new 100-bed greenfield hospital was formally inaugurated in Rajahmundry, Andhra Pradesh. This facility is positioned as a regional hub to serve the East and West Godavari regions, strengthening the company's footprint in the state.

• Shareholding Structure (as of Dec 31, 2025)

• Promoter & Promoter Group: 49.8%

• Institutional Holdings: Mutual Funds & AIFs hold 17.2%, while FPIs & NRIs hold 19.5%.

• Key Institutional Investors: Notable shareholders include DSP Mutual Fund (4.32%), Franklin Templeton MF (2.81%), ICICI Prudential (2.80%), Abu Dhabi Investment Authority (2.01%), and Kuwait Investment Authority (1.02%).

Recent strategic updates, including strengthening the leadership team and expanding the network, combined with a strong institutional shareholder base, reinforce the company's growth trajectory.